CLOs provide an efficient, scalable way of investing in floating-rate loans while offering structural protection that has historically performed well through multiple credit cycles. A collateralized loan obligation (CLO) is
Core consumer prices in Japan’s capital, a leading indicator of nationwide trends, rose 4.3% in January from a year earlier, marking the fastest annual gain in nearly 42 years and
Helios is a rugged Commercial Off the Shelf (COTS) vision computer system optimized for Size, Weight, Power and Cost (SWaP-C) designed to operate in harsh environments. The system is based
Early-stage investment and development company Cadence Minerals has completed the sale of 30% of its working interests in the Western Australia-based Yangibana rare earths project tenements to Australia-based rare earths company Hastings Technology Metals.
Testimonial: Chris Mair, General Manager at Pennant International Ltd Fareham The OmegaPS LSAR Software suite is an Internationally recognised industry strength Integrated Logistic Support (ILS) application, developed over 28 years
Volta Finance (LON:VTA, LON:VTAS) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk Interviews. Mark talks us through his latest report entitled ‘R&A shining light
The recent positive developments in Nanoco’s patent infringement lawsuit against Samsung in the US, highlight the possibilities for universities, their technology transfer offices or spin-outs to realise the value of their
Domain name scams on the internet have become quite common over the past few years. With the proliferation of digital technologies these domain name scams are utilized by scamsters to
Many home-movers have already been putting their 2023 moving plans into action, with average asking prices seeing the biggest New Year bounce in three years. Our monthly House Price Index has the
Hardman and Co’s Dr Martin Hall discusses Advanced Oncotherapy plc in this exclusive interview with DirectorsTalk.
© 2022 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
